D. Toumpanakis (Athens, Greece), M. Presotto (Heidelberg, Germany)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Passive Microwave Radiometry (MWR) for diagnostics of COVID-19 lung complications in Kyrgyzstan. B. Osmonov (Bishkek, Kyrgyzstan), L. Ovchinnikov (Bishkek, United Kingdom), C. Galazis (Bishkek, United Kingdom), B. Emilov (Bishkek, Kyrgyzstan), M. Karaibragimov (Bishkek, Kyrgyzstan), M. Seitov (Bishkek, Kyrgyzstan), I. Goryanin (Bishkek, United Kingdom)
|   |
Local incidence and outcomes of patients with pneumothorax and pneumomediastinum in COVID-19 K. Jackson (Newcastle, United Kingdom), A. Aujayeb (Newcastle, United Kingdom), A. Aujayeb (newcastle, Mauritius)
|   |
What can we learn about oxygen therapy from the Nightingale North West experience? S. Stolberg (Manchester, United Kingdom), S. Ali (Liverpool, United Kingdom), S. Sibley (Liverpool, United Kingdom)
|   |
Oximetry and acid-base balance features in pregnant women with pneumonia caused by SARS-COV-2 I. Andrievskaya (Blagoveshchensk, Russian Federation), . Zhukovets (Blagoveshchensk, Russian Federation), V. Bardov (Blagoveshchensk, Russian Federation), . Ishutina (Blagoveshchensk, Russian Federation), I. Dovzhikova (Blagoveshchensk, Russian Federation), A. Abuldinov (Blagoveshchensk, Russian Federation), K. Lyazgian (Blagoveshchensk, Russian Federation), V. Kolosov (Blagoveshchensk, Russian Federation)
|   |
Happy Hypoxia: A case series T. Kulkarni (Mumbai (Maharashtra), India), M. Mengar (Mumbai (Maharashtra), India), A. Dalal (Mumbai (Maharashtra), India)
|   |
The implementation of routine breathlessness and cough scoring in a virtual early supported discharge service for COVID-19. K. Rhatigan (London, United Kingdom), C. Jolley (London, United Kingdom), J. Fenton (London, United Kingdom), S. Ramos-Smyth (London, United Kingdom), M. Ford-Adams (London, United Kingdom), A. Patel (London, United Kingdom), P. Cho (London, United Kingdom), I. Patel (London, United Kingdom), S. Birring (London, United Kingdom)
|   |
Point-of-care anti-SARS-CoV-2 antibody testing: results from the PRACTICES Study G. Long (Lancaster, United Kingdom), M. Munavvar (Lancaster, United Kingdom)
|  |
Appropriately timed COVID-19 PCR testing for hospital inpatients. Z. Raffeeq (Telford, United Kingdom), N. Ahmad (Telford, United Kingdom), E. Crawford (Telford, United Kingdom), D. Dev (Telford, United Kingdom), A. Makan (Telford, United Kingdom), K. Srinivasan (Telford, United Kingdom), H. Moudgil (Telford, United Kingdom)
|   |
Diagnostic value of high fever to predict polymerase chain reaction (PCR) status in patients with Novel Coronavirus (COVID-19) pneumonia E. Tellioglu (Izmir, Turkey), A. Mertoglu (Izmir, Turkey), G. Balci (Izmir, Turkey), A. Bayram (Izmir, Turkey), N. Kuranoglu (Izmir, Turkey), A. Çirak (Izmir, Turkey), Ö. Ediboglu (Izmir, Turkey), G. Erbay Polat (Izmir, Turkey)
|   |
Protective effect of BCG revaccination in health care workers against COVID-19: A Myth or Game Changer? S. Saini (Gurugram, India), D. Sudan (Gurugram, India), S. Dawar (Gurugram, India), A. Jokhi (Gurugram, India)
|   |
Clinical features and outcome of COVID-19 pneumonia in haemodialysis patients F. Bini (Garbagnate Milanese, Italy), B. Bodini (Garbagnate Milanese, Italy), M. Bongiovanni (Garbagnate Milanese, Italy), A. De Lauretis (Garbagnate Milanese, Italy), A. Marra (Garbagnate Milanese, Italy), A. Pistone (Garbagnate Milanese, Italy), N. Grassi (Garbagnate Milanese, Italy)
|   |
Late Breaking Abstract - Treatment with ATYR1923 reduces biomarkers in COVID-19 pneumonia R. Adams (San Diego, United States of America), G. Walker (San Diego, United States of America), L. Guy (San Diego, United States of America), L. Sitts (San Diego, United States of America), N. Kinnersley (Harpenden, United Kingdom), L. Carey (San Diego, United States of America), L. Nangle (San Diego, United States of America), S. Shukla (San Diego, United States of America)
|   |
Late Breaking Abstract - Acute multi-organ symptoms predict long COVID S. Sahanic (Innsbruck, Austria), P. Tymoszuk (Innsbruck, Austria), D. Ausserhofer (Bolzano, Italy), V. Rass (Innsbruck, Austria), A. Pizzini (Innsbruck, Austria), G. Nordmeyer (Innsbruck, Austria), K. Hüfner (Innsbruck, Austria), K. Kurz (Innsbruck, Austria), P. Weber (Innsbruck, Austria), T. Sonnweber (Innsbruck, Austria), A. Boehm (Innsbruck, Austria), M. Aichner (Innsbruck, Austria), K. Cima (Innsbruck, Austria), B. Böckle (Innsbruck, Austria), C. Gollmann-Tepeköylü (Innsbruck, Austria), J. Holfeld (Innsbruck, Austria), S. Kiechl (Innsbruck, Austria), A. Huber (Innsbruck, Austria), C. Wiedermann (Bolzano, Italy), B. Sperner-Unterweger (Innsbruck, Austria), R. Bellmann-Weiler (Innsbruck, Austria), H. Bachler (Innsbruck, Austria), G. Piccoliori (Bolzano, Italy), R. Helbok (Innsbruck, Austria), G. Weiss (Innsbruck, Austria), J. Löffler-Ragg (Innsbruck, Austria)
|   |
Treatment With Baricitinib for Patients With COVID-19 Infections: A Case-Series Study C. Ravaglia (Forlì, Italy), S. Piciucchi (Forlì, Italy), S. Oldani (Forlì, Italy), L. Bertolovic (Forlì, Italy), S. Bensai (Forlì, Italy), C. Colinelli (Forlì, Italy), S. Simoncelli (Forlì, Italy), C. Ghirotti (Forlì, Italy), S. Puglisi (Forlì, Italy), L. Donati (Forlì, Italy), G. Ravaglia (Forlì, Italy), F. Landi (Forlì, Italy), M. Terzitta (Forlì, Italy), V. Poletti (Forlì, Italy)
|   |
Effectiveness of corticosteroids on HRCT features of COVID 19 pneumonia C. Calabrese (Napoli (NA), Italy), A. Annunziata (Napoli (NA), Italy), M. Mollica (Napoli (NA), Italy), P. Imitazione (Napoli (NA), Italy), M. Lanza (Napoli (NA), Italy), G. Polistina (Napoli (NA), Italy), M. Flora (Napoli (NA), Italy), S. Guarino (Napoli (NA), Italy), C. Palumbo (Napoli (NA), Italy), P. Pafundi (Napoli (NA), Italy), G. Fiorentino (Napoli (NA), Italy)
|   |
Evaluating the accuracy of pulse oximetry: Finger probe versus earlobe probe in patients with confirmed or suspected COVID-19 within the community setting. E. Rickards (Liverpool, United Kingdom), S. Miller (Liverpool, United Kingdom), O. Hampson (Liverpool, United Kingdom), D. Wat (Liverpool, United Kingdom)
|   |
ENO breathe: An arts and health alliance to help COVID-19 recovery. H. Owles (London, United Kingdom), J. Mollica (London, United Kingdom), T. Pagnuco (London, United Kingdom), S. Zumpe (London, United Kingdom), L. Anderson (London, United Kingdom), T. Hardy (London, United Kingdom), G. Russell (London, United Kingdom), A. Lound (London, United Kingdom), M. Maguire (London, United Kingdom), V. Padmanaban (London, United Kingdom), H. Brunjes (London, United Kingdom), N. Hopkinson (London, United Kingdom), S. Elkin (London, United Kingdom)
|   |
Late Breaking Abstract - Biomarkers for iron metabolism among patients hospitalized with community-acquired pneumonia caused by SARS-CoV-2, bacteria, and influenza M. Hegelund (Hillerød, Denmark), A. Glenthøj (Copenhagen , Denmark), C. Ryrsø (Hillerød, Denmark), C. Ritz (Frederiksberg, Denmark), A. Dungu (Hillerød, Denmark), A. Sejdic (Hillerød, Denmark), K. List (Copenhagen, Denmark), R. Krogh-Madsen (Copenhagen, Denmark), B. Lindegaard (Copenhagen, Denmark), J. Kurtzhals (Copenhagen, Denmark), D. Faurholt-Jepsen (Copenhagen, Denmark)
|   |
Managing COVID-19 illness: chest radiographs support defining both prognosis and follow up. S. Ahmed (Telford (Shropshire), United Kingdom), Z. Ali (Telford (Shropshire), United Kingdom), A. Makan (Telford (Shropshire), United Kingdom), E. Crawford (Telford (Shropshire), United Kingdom), D. Dev (Telford (Shropshire), United Kingdom), K. Srinivasan (Telford (Shropshire), United Kingdom), N. Ahmad (Telford (Shropshire), United Kingdom), H. Moudgil (Telford (Shropshire), United Kingdom)
|   |